The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
807
December 15, 1989
View Complete Issue         Table of Contents 2019 
Malathion For Head Lice
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Malathion For Head Lice
December 15, 1989 (Issue: 807)
Ovide Lotion (GenDerm), 0.5% malathion in 78% alcohol, was recently approved by the US Food and Drug Administration for treatment of head lice; it is available only by prescription. A previous formulation of malathion (Prioderm Lotion - Medical...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Malathion For Head Lice
Article code: 807b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.